Medical and Surgical Management of Advanced Parkinson's Disease
- 1 June 2018
- journal article
- review article
- Published by Wiley in Movement Disorders
- Vol. 33 (6), 900-908
- https://doi.org/10.1002/mds.27340
Abstract
Advanced Parkinson's disease is characterized by the presence of motor fluctuations, various degree of dyskinesia, and disability with functional impact on activities of daily living and independence. Therapeutic management aims to extend levodopa benefit while minimizing motor complications and includes, in selected cases, the implementation of drug infusion and surgical techniques. In milder forms of motor complications, these can often be controlled with manipulation of levodopa dose and the introduction of supplemental therapies such as catechol-O-methyl transferase inhibitors, monoamine oxidase B inhibitors, and dopamine agonists including apomorphine. Clinical experience and evidence from published studies indicate that when these agents cannot satisfactorily control motor complications, patients should be assessed and considered for device-aided therapies. This review article summarizes some of the newer available therapeutic opportunities such as use of enzyme inhibitors like opicapone and safinamide, adenosine A(2A) receptor antagonists, apomorphine and levodopa/carbidopa intestinal gel infusion, deep brain stimulation including the role of closed-loop and adaptive stimulation, and MRI-guided focused ultrasound. (C) 2018 International Parkinson and Movement Disorder SocietyKeywords
This publication has 95 references indexed in Scilit:
- Adaptive deep brain stimulation (aDBS) controlled by local field potential oscillationsExperimental Neurology, 2013
- Neurostimulation for Parkinson's Disease with Early Motor ComplicationsNew England Journal of Medicine, 2013
- Wearing‐off scales in Parkinson's disease: Critique and recommendationsMovement Disorders, 2011
- Initiating levodopa/carbidopa therapy with and without entacapone in early Parkinson disease: The STRIDE‐PD studyAnnals of Neurology, 2010
- Cognition and mood in Parkinson's disease in subthalamic nucleus versus globus pallidus interna deep brain stimulation: The COMPARE TrialAnnals of Neurology, 2009
- Bilateral Deep Brain Stimulation vs Best Medical Therapy for Patients With Advanced Parkinson DiseaseA Randomized Controlled TrialJAMA, 2009
- Relationship between weight, levodopa and dyskinesia: the significance of levodopa dose per kilogram body weightEuropean Journal of Neurology, 2008
- Duodenal levodopa infusion for advanced Parkinson's disease: 12‐month treatment outcomeMovement Disorders, 2007
- Entacapone to tolcapone switch: Multicenter double‐blind, randomized, active‐controlled trial in advanced Parkinson's diseaseMovement Disorders, 2007
- Selegiline and mortality in Parkinson's disease: Another viewAnnals of Neurology, 1997